Injectable Peptides
26 articles on Injectable Peptides, researched and written by the Shotlee Editorial Team from primary sources.
Peptides Get Their Regulatory Close-Up at FDA Review
The FDA is convening a panel to review regulations on popular injectable peptides. Learn about safety concerns, clinical evidence gaps, and what this means for patient access to peptide therapy.
8 min read
Black-Market Peptide Surge Strains Needle and Syringe Programs
The rise of unregulated peptides for performance and image enhancement is placing significant pressure on vital harm reduction services, originally established to combat HIV. These programs are now facing increased demand and potential shortages of essential supplies.
7 min read
Peptide Hype: Do They Live Up to the Claims for Skin and Wellness?
From skincare routines to GLP-1 weight loss medications, peptides are everywhere. But do they deliver on their promises for skin health, longevity, and recovery? This article delves into the science and the trend.
9 min read
Illegal Peptide Shots in Brazil: The Hidden Risks for Expats
Foreign residents in Brazil face a growing grey market of unregulated injectable peptides. Here is what the health regulator Anvisa says about safety and legality.
7 min read
Peptides: Fad or Future? Unpacking the Hype for Skin, Weight Loss & More
From celebrity endorsements to GLP-1 weight loss drugs, peptides are everywhere. But what exactly are they, and can they deliver on their promises for skin health, longevity, and more? This article dives into the science, the trends, and the risks.
7 min read
Beyond the Hype: Black Market Peptides Strain Vital Health Services
The booming trade in unregulated peptides for weight loss and body enhancement is placing unprecedented pressure on essential harm reduction services, originally established to combat the HIV epidemic. This article delves into the challenges, risks, and urgent needs arising from this new wave of drug use.
7 min read
Beyond the Hype: Navigating the Rise of Online Peptides
A surge in injectable peptides marketed online for enhancement purposes is outpacing regulatory oversight, creating a 'grey zone' with potential public health implications. This article delves into the complexities, risks, and what consumers should understand.
6 min read
Ozempic, Wegovy & Mounjaro: AI Uncovers New Patient-Reported Side Effects
New research leverages AI to sift through vast online discussions, identifying patient-reported side effects of popular GLP-1 medications that may not be fully captured in clinical trials.
7 min read
Ozempic, Mounjaro & More: AI Uncovers Hidden GLP-1 Side Effects
Popular GLP-1 medications such as semaglutide and tirzepatide are revolutionizing weight loss and diabetes management. A groundbreaking study using AI to analyze over 400,000 Reddit posts has shed light on potential side effects that may not be fully captured in traditional clinical trials, offering valuable insights for patients and healthcare providers.
7 min read
Looksmaxxing: The Risky Trend of Extreme Self-Improvement
Looksmaxxing, a trend focused on extreme self-improvement and physical optimization, has gained significant traction online. While some aspects involve standard grooming and fitness, others venture into dangerous territory, including bone-smashing and unregulated injectable substances. This article delves into the spectrum of looksmaxxing, its psychological underpinnings, and the serious health risks associated with its more extreme practices.
8 min read
Understanding Peptides: Beyond the Hype of GLP-1s and Skincare
Peptides are powerful signaling molecules, but they are not a universal cure-all. This deep dive clarifies the function of GLP-1 agonists, cosmetic peptides, and the critical importance of medical guidance when considering peptide therapies for weight management or anti-aging.
6 min read
Peptide Use Among Young Men: The Pursuit of Perfection and Potential Risks
The quest for physical perfection is driving a new trend among teen boys and young men: the use of unapproved peptides. This article delves into the motivations, the substances involved, and the significant health concerns surrounding this practice.
8 min read
Peptide Therapy & The Biohacking Boom: Navigating Unregulated Wellness
The world of biohacking is increasingly embracing peptides, but what's the reality behind the hype? This article delves into the science, the risks of unregulated substances, and the potential impact of regulatory changes on access to these compounds.
10 min read
Health Canada Warns Against Buying Peptides Online—CBC News Buys Them Easily
Health Canada recently warned Canadians not to buy or use unauthorized injectable peptide drugs amid reports of adverse reactions. Yet CBC News effortlessly purchased three such products online from different sellers. Experts highlight serious risks and contrast them with regulated GLP-1 medications like Ozempic and Wegovy.
5 min read
What's Behind the Injectable Peptide Craze?
Grey-market injectable peptides such as BPC-157, GHK-Cu, and TB-500 have captured the attention of biohackers and health optimizers. In this guide based on a revealing podcast, journalist Adrienne Matei and Dr. Anna Barnard from Imperial College London unpack the science, appeal, and uncertainties behind the craze.
5 min read
RFK Jr. Misrepresents Ex-FDA Officials in Push to Lift Peptide Ban
Health Secretary RFK Jr. is pushing to lift the FDA's ban on 19 peptides used in compounding pharmacies, claiming the decision was illegal with no safety signals. But former FDA officials, including Janet Woodcock, say he misrepresents their views amid documented risks like immune reactions and trial fatalities. As demand surges via influencers, recent illnesses highlight the stakes in this regulatory battle.
6 min read
Injectable Peptides Touted as Fountain of Youth: Science Lags
From crocodile droppings to modern injectable peptides, the quest for eternal youth persists. Influencers promote unregulated peptides as miracle anti-aging shots, but scientists warn of empty evidence and serious risks. While approved peptides like Ozempic have solid research, grey market options lack safety data.
5 min read
RFK Jr. Big Fan of Peptides: FDA Ban May Lift Soon
Health Secretary RFK Jr. revealed on Joe Rogan's podcast that the FDA may soon act on injectable peptides, which he supports making more accessible. Banned in 2023 for safety risks, these short amino acid chains show promise in anti-aging, muscle building, and more. Here's what peptides are and the debate surrounding them.
5 min read
RFK Jr.'s Peptide Push: Risks of Bypassing FDA Trials
Robert F. Kennedy Jr., US health secretary nominee, wants to open sales of restricted injectable peptides, fitting his Make America Healthy Again agenda. While some peptides show promise, the FDA halted 17 in 2023 due to safety risks—without trials, anecdote isn't evidence. This editorial warns against sidelining regulation for wellness hucksters.
4 min read
Supplement Makers Push FDA to Allow Peptides, New Ingredients
Makers of dietary supplements are pressing the FDA to permit peptides, probiotics, and other trendy ingredients not traditionally found in food. A pivotal public meeting highlighted industry pleas, RFK Jr.'s support, and warnings from consumer advocates. Here's what to know about this regulatory push reshaping the $100B+ supplement market.
6 min read
Supplement Makers Push FDA to Allow Peptides and New Ingredients
Dietary supplement makers are pressing the FDA to broaden ingredient criteria, potentially greenlighting peptides and probiotics not traditionally found in food. A key public meeting highlighted industry pleas under RFK Jr.'s health leadership, sparking debates on safety and oversight. Here's what this means for the booming wellness market.
6 min read
Peptide Boom: Legal Loophole Fuels Unregulated Injectables Rise
A legal 'loophole' is fueling a boom in unregulated injectable peptides sold online as 'research only' products, despite warnings they're unsafe for human use. Fitness enthusiasts inject BPC-157 and TB-500 for healing, while unapproved Retatrutide draws weight loss seekers. Experts urge caution amid contamination risks and MHRA crackdowns.
6 min read
Hims & Hers Opens $149 Wegovy & Ozempic Waitlist via Novo Deal
Hims & Hers Health (NYSE: HIMS) is now offering a waitlist for affordable branded Wegovy and Ozempic at $149, thanks to a new Novo Nordisk deal. This expands access to these popular GLP-1 weight-loss drugs amid high demand. Meanwhile, HIMS stock shows short-term rebound potential in a downtrend—dive into the technicals and analyst views.
5 min read
Could You Be Allergic to Your GLP-1 Medication?
Social media buzz highlights itchy skin as a surprising side effect of GLP-1 medications like semaglutide (Ozempic, Wegovy). Patients report hives and mosquito-like bites after doses. Dermatologists and weight loss experts break down causes from allergies to rapid weight loss and offer practical advice.
6 min read
Why Gym Bros Are Talking About Peptides: Hype, Science & Cautions
Peptides are everywhere on TikTok, with gym bros claiming stacks like Ipamorelin and CJC1295 supercharge muscle growth and recovery. But do these injectable amino acid chains really deliver, or is it hype? Experts weigh in on the science, safety, and why caution is key amid a $81.5 billion industry boom.
6 min read
Peptide Therapy for Weight Management: Long-Term Strategies and the Role of Health Tracking
Explore the complexities of weight management with peptide therapies like GLP-1 agonists. Learn about long-term strategies, the role of microdosing, and how health tracking tools like Shotlee can support your wellness journey.